APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alpha N-Acetylglucosaminidase

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alpha N-Acetylglucosaminidase Industry Growth and Trends Forecast to 2032

19 December 202598 pages

Choose your research edition.

Industry ResearchAlpha N-Acetylglucosaminidase Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha N-Acetylglucosaminidase Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Alpha N-Acetylglucosaminidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha N-Acetylglucosaminidase Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha N-Acetylglucosaminidase Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Alpha N-Acetylglucosaminidase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alpha N-Acetylglucosaminidase include UniQure N.V., Laboratorios Del Dr. Esteve S.A., Dorphan S.A., BioMarin Pharmaceutical Inc., Alexion Pharmaceuticals, Inc. and Abeona Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alpha N-Acetylglucosaminidase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alpha N-Acetylglucosaminidase market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alpha N-Acetylglucosaminidase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alpha N-Acetylglucosaminidase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alpha N-Acetylglucosaminidase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alpha N-Acetylglucosaminidase Market by Company

UniQure N.V.

Laboratorios Del Dr. Esteve S.A.

Dorphan S.A.

BioMarin Pharmaceutical Inc.

Alexion Pharmaceuticals, Inc.

Abeona Therapeutics, Inc.

Alpha N-Acetylglucosaminidase Segment by Type

Lesinidase Alfa

EGT-201

BMN-250

ABO-101

Others

Alpha N-Acetylglucosaminidase Segment by Application

In-Patient

Out-Patient

Alpha N-Acetylglucosaminidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha N-Acetylglucosaminidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha N-Acetylglucosaminidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha N-Acetylglucosaminidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alpha N-Acetylglucosaminidase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alpha N-Acetylglucosaminidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lesinidase Alfa Table 2. Major Company of EGT-201 Table 3. Major Company of BMN-250 Table 4. Major Company of ABO-101 Table 5. Major Company of Others Table 6. Global Alpha N-Acetylglucosaminidase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (K Units) Table 8. Global Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Type (2021-2026) Table 9. Global Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (US$ Million) Table 10. Global Alpha N-Acetylglucosaminidase Sales Market Share in Value by Type (2021-2026) Table 11. Global Alpha N-Acetylglucosaminidase Price by Type (2021-2026) & (US$/Unit) Table 12. Global Alpha N-Acetylglucosaminidase Sales by Type (2027-2032) & (K Units) Table 13. Global Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Type (2027-2032) Table 14. Global Alpha N-Acetylglucosaminidase Sales by Type (2027-2032) & (US$ Million) Table 15. Global Alpha N-Acetylglucosaminidase Sales Market Share in Value by Type (2027-2032) Table 16. Global Alpha N-Acetylglucosaminidase Price by Type (2027-2032) & (US$/Unit) Table 17. North America Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (K Units) Table 18. North America Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (K Units) Table 20. Europe Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (K Units) Table 24. Latin America Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (US$ Million) Table 27. Alpha N-Acetylglucosaminidase Industry Trends Table 28. Alpha N-Acetylglucosaminidase Industry Drivers Table 29. Alpha N-Acetylglucosaminidase Industry Opportunities and Challenges Table 30. Alpha N-Acetylglucosaminidase Industry Restraints Table 31. Global Alpha N-Acetylglucosaminidase Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Company (2021-2026) Table 33. Global Alpha N-Acetylglucosaminidase Sales by Company (2021-2026) & (K Units) Table 34. Global Alpha N-Acetylglucosaminidase Sales Share by Company (2021-2026) Table 35. Global Alpha N-Acetylglucosaminidase Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Alpha N-Acetylglucosaminidase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Alpha N-Acetylglucosaminidase Major Company Production Sites and Headquarters Table 38. Global Alpha N-Acetylglucosaminidase Company, Product Type & Application Table 39. Global Alpha N-Acetylglucosaminidase Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Alpha N-Acetylglucosaminidase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Alpha N-Acetylglucosaminidase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Alpha N-Acetylglucosaminidase Sales by Region (2021-2026) & (K Units) Table 44. Global Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Region (2021-2026) Table 45. Global Alpha N-Acetylglucosaminidase Sales by Region (2021-2026) & (US$ Million) Table 46. Global Alpha N-Acetylglucosaminidase Sales Market Share in Value by Region (2021-2026) Table 47. Global Alpha N-Acetylglucosaminidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Alpha N-Acetylglucosaminidase Sales by Region (2027-2032) & (K Units) Table 49. Global Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Region (2027-2032) Table 50. Global Alpha N-Acetylglucosaminidase Sales by Region (2027-2032) & (US$ Million) Table 51. Global Alpha N-Acetylglucosaminidase Sales Market Share in Value by Region (2027-2032) Table 52. Global Alpha N-Acetylglucosaminidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Alpha N-Acetylglucosaminidase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (K Units) Table 55. Global Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Application (2021-2026) Table 56. Global Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (US$ Million) Table 57. Global Alpha N-Acetylglucosaminidase Sales Market Share in Value by Application (2021-2026) Table 58. Global Alpha N-Acetylglucosaminidase Price by Application (2021-2026) & (US$/Unit) Table 59. Global Alpha N-Acetylglucosaminidase Sales by Application (2027-2032) & (K Units) Table 60. Global Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Application (2027-2032) Table 61. Global Alpha N-Acetylglucosaminidase Sales by Application (2027-2032) & (US$ Million) Table 62. Global Alpha N-Acetylglucosaminidase Sales Market Share in Value by Application (2027-2032) Table 63. Global Alpha N-Acetylglucosaminidase Price by Application (2027-2032) & (US$/Unit) Table 64. North America Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (K Units) Table 65. North America Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (K Units) Table 67. Europe Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (K Units) Table 71. Latin America Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (US$ Million) Table 74. UniQure N.V. Company Information Table 75. UniQure N.V. Business Overview Table 76. UniQure N.V. Alpha N-Acetylglucosaminidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. UniQure N.V. Alpha N-Acetylglucosaminidase Product Portfolio Table 78. UniQure N.V. Recent Development Table 79. Laboratorios Del Dr. Esteve S.A. Company Information Table 80. Laboratorios Del Dr. Esteve S.A. Business Overview Table 81. Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Product Portfolio Table 83. Laboratorios Del Dr. Esteve S.A. Recent Development Table 84. Dorphan S.A. Company Information Table 85. Dorphan S.A. Business Overview Table 86. Dorphan S.A. Alpha N-Acetylglucosaminidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Dorphan S.A. Alpha N-Acetylglucosaminidase Product Portfolio Table 88. Dorphan S.A. Recent Development Table 89. BioMarin Pharmaceutical Inc. Company Information Table 90. BioMarin Pharmaceutical Inc. Business Overview Table 91. BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Product Portfolio Table 93. BioMarin Pharmaceutical Inc. Recent Development Table 94. Alexion Pharmaceuticals, Inc. Company Information Table 95. Alexion Pharmaceuticals, Inc. Business Overview Table 96. Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Product Portfolio Table 98. Alexion Pharmaceuticals, Inc. Recent Development Table 99. Abeona Therapeutics, Inc. Company Information Table 100. Abeona Therapeutics, Inc. Business Overview Table 101. Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Product Portfolio Table 103. Abeona Therapeutics, Inc. Recent Development Table 104. North America Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. North America Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 106. North America Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2026) Table 107. North America Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032) & (K Units) Table 108. North America Alpha N-Acetylglucosaminidase Sales Market Share Forecast by Country (2027-2032) Table 109. North America Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. North America Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026) & (US$ Million) Table 111. North America Alpha N-Acetylglucosaminidase Market Share by Country (2021-2026) Table 112. North America Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. North America Alpha N-Acetylglucosaminidase Market Share Forecast by Country (2027-2032) Table 114. Europe Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Europe Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 116. Europe Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2026) Table 117. Europe Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032) & (K Units) Table 118. Europe Alpha N-Acetylglucosaminidase Sales Market Share Forecast by Country (2027-2032) Table 119. Europe Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Europe Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026) & (US$ Million) Table 121. Europe Alpha N-Acetylglucosaminidase Market Share by Country (2021-2026) Table 122. Europe Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Europe Alpha N-Acetylglucosaminidase Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 126. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2026) Table 127. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032) & (K Units) Table 128. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026) & (US$ Million) Table 131. Asia-Pacific Alpha N-Acetylglucosaminidase Market Share by Country (2021-2026) Table 132. Asia-Pacific Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Asia-Pacific Alpha N-Acetylglucosaminidase Market Share Forecast by Country (2027-2032) Table 134. Latin America Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Latin America Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 136. Latin America Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2026) Table 137. Latin America Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032) & (K Units) Table 138. Latin America Alpha N-Acetylglucosaminidase Sales Market Share Forecast by Country (2027-2032) Table 139. Latin America Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Latin America Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026) & (US$ Million) Table 141. Latin America Alpha N-Acetylglucosaminidase Market Share by Country (2021-2026) Table 142. Latin America Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Latin America Alpha N-Acetylglucosaminidase Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 146. Middle East and Africa Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2026) Table 147. Middle East and Africa Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032) & (K Units) Table 148. Middle East and Africa Alpha N-Acetylglucosaminidase Sales Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Alpha N-Acetylglucosaminidase Market Share by Country (2021-2026) Table 152. Middle East and Africa Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Middle East and Africa Alpha N-Acetylglucosaminidase Market Share Forecast by Country (2027-2032) Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Alpha N-Acetylglucosaminidase Distributors List Table 157. Alpha N-Acetylglucosaminidase Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Alpha N-Acetylglucosaminidase Image Figure 2. Global Alpha N-Acetylglucosaminidase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha N-Acetylglucosaminidase Market Size (2021-2032) & (US$ Million) Figure 4. Global Alpha N-Acetylglucosaminidase Sales (2021-2032) & (K Units) Figure 5. Lesinidase Alfa Image Figure 6. Global Lesinidase Alfa Sales YoY Growth (2021-2032) & (K Units) Figure 7. EGT-201 Image Figure 8. Global EGT-201 Sales YoY Growth (2021-2032) & (K Units) Figure 9. BMN-250 Image Figure 10. Global BMN-250 Sales YoY Growth (2021-2032) & (K Units) Figure 11. ABO-101 Image Figure 12. Global ABO-101 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Alpha N-Acetylglucosaminidase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Alpha N-Acetylglucosaminidase Market Share by Type 2025 VS 2032 Figure 17. North America Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Type in 2025 Figure 18. North America Alpha N-Acetylglucosaminidase Sales Market Share in Value by Type in 2025 Figure 19. Europe Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Type in 2025 Figure 20. Europe Alpha N-Acetylglucosaminidase Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Market Share in Value by Type in 2025 Figure 23. Latin America Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Alpha N-Acetylglucosaminidase Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Alpha N-Acetylglucosaminidase Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Alpha N-Acetylglucosaminidase Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. In-Patient Image Figure 30. Global In-Patient Sales YoY Growth (2021-2032) & (K Units) Figure 31. Out-Patient Image Figure 32. Global Out-Patient Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Alpha N-Acetylglucosaminidase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Alpha N-Acetylglucosaminidase Market Share by Application 2025 VS 2032 Figure 35. North America Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Application in 2025 Figure 36. North America Alpha N-Acetylglucosaminidase Sales Market Share in Value by Application in 2025 Figure 37. Europe Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Application in 2025 Figure 38. Europe Alpha N-Acetylglucosaminidase Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Market Share in Value by Application in 2025 Figure 41. Latin America Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Alpha N-Acetylglucosaminidase Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Alpha N-Acetylglucosaminidase Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Alpha N-Acetylglucosaminidase Sales Market Share in Value by Application in 2025 Figure 45. North America Alpha N-Acetylglucosaminidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Alpha N-Acetylglucosaminidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Alpha N-Acetylglucosaminidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Alpha N-Acetylglucosaminidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Alpha N-Acetylglucosaminidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Alpha N-Acetylglucosaminidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Alpha N-Acetylglucosaminidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Alpha N-Acetylglucosaminidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Alpha N-Acetylglucosaminidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Alpha N-Acetylglucosaminidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Alpha N-Acetylglucosaminidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Alpha N-Acetylglucosaminidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Alpha N-Acetylglucosaminidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Alpha N-Acetylglucosaminidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Alpha N-Acetylglucosaminidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Alpha N-Acetylglucosaminidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Alpha N-Acetylglucosaminidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Alpha N-Acetylglucosaminidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Alpha N-Acetylglucosaminidase Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Alpha N-Acetylglucosaminidase Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Lesinidase Alfa
  • EGT-201
  • BMN-250
  • ABO-101
  • Others
Applications
  • In-Patient
  • Out-Patient
Companies covered
  • UniQure N.V.
  • Laboratorios Del Dr. Esteve S.A.
  • Dorphan S.A.
  • BioMarin Pharmaceutical Inc.
  • Alexion Pharmaceuticals, Inc.
  • Abeona Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alpha N-Acetylglucosaminidase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alpha N-Acetylglucosaminidase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alpha N-Acetylglucosaminidase Market by Type
  6. 1.3.1 Lesinidase Alfa
  7. 1.3.2 EGT-201
  8. 1.3.3 BMN-250
  9. 1.3.4 ABO-101
  10. 1.3.5 Others
  11. 1.4 Global Alpha N-Acetylglucosaminidase Market Size by Type
  12. 1.4.1 Global Alpha N-Acetylglucosaminidase Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Alpha N-Acetylglucosaminidase Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Alpha N-Acetylglucosaminidase Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Alpha N-Acetylglucosaminidase Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Alpha N-Acetylglucosaminidase Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Alpha N-Acetylglucosaminidase Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Alpha N-Acetylglucosaminidase Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Alpha N-Acetylglucosaminidase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alpha N-Acetylglucosaminidase Industry Trends
  2. 2.2 Alpha N-Acetylglucosaminidase Industry Drivers
  3. 2.3 Alpha N-Acetylglucosaminidase Industry Opportunities and Challenges
  4. 2.4 Alpha N-Acetylglucosaminidase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alpha N-Acetylglucosaminidase Revenue (2021-2026)
  2. 3.2 Global Top Players by Alpha N-Acetylglucosaminidase Sales (2021-2026)
  3. 3.3 Global Top Players by Alpha N-Acetylglucosaminidase Price (2021-2026)
  4. 3.4 Global Alpha N-Acetylglucosaminidase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alpha N-Acetylglucosaminidase Major Company Production Sites & Headquarters
  6. 3.6 Global Alpha N-Acetylglucosaminidase Company, Product Type & Application
  7. 3.7 Global Alpha N-Acetylglucosaminidase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alpha N-Acetylglucosaminidase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alpha N-Acetylglucosaminidase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alpha N-Acetylglucosaminidase Tier 1, Tier 2, and Tier 3
4 Alpha N-Acetylglucosaminidase Regional Status and Outlook
  1. 4.1 Global Alpha N-Acetylglucosaminidase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alpha N-Acetylglucosaminidase Historic Market Size by Region
  3. 4.2.1 Global Alpha N-Acetylglucosaminidase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alpha N-Acetylglucosaminidase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alpha N-Acetylglucosaminidase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alpha N-Acetylglucosaminidase Forecasted Market Size by Region
  7. 4.3.1 Global Alpha N-Acetylglucosaminidase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alpha N-Acetylglucosaminidase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alpha N-Acetylglucosaminidase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alpha N-Acetylglucosaminidase by Application
  1. 5.1 Alpha N-Acetylglucosaminidase Market by Application
  2. 5.1.1 In-Patient
  3. 5.1.2 Out-Patient
  4. 5.2 Global Alpha N-Acetylglucosaminidase Market Size by Application
  5. 5.2.1 Global Alpha N-Acetylglucosaminidase Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Alpha N-Acetylglucosaminidase Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Alpha N-Acetylglucosaminidase Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Alpha N-Acetylglucosaminidase Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Alpha N-Acetylglucosaminidase Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Alpha N-Acetylglucosaminidase Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Alpha N-Acetylglucosaminidase Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Alpha N-Acetylglucosaminidase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 UniQure N.V.
  2. 6.1.1 UniQure N.V. Company Information
  3. 6.1.2 UniQure N.V. Business Overview
  4. 6.1.3 UniQure N.V. Alpha N-Acetylglucosaminidase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 UniQure N.V. Alpha N-Acetylglucosaminidase Product Portfolio
  6. 6.1.5 UniQure N.V. Recent Developments
  7. 6.2 Laboratorios Del Dr. Esteve S.A.
  8. 6.2.1 Laboratorios Del Dr. Esteve S.A. Company Information
  9. 6.2.2 Laboratorios Del Dr. Esteve S.A. Business Overview
  10. 6.2.3 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Product Portfolio
  12. 6.2.5 Laboratorios Del Dr. Esteve S.A. Recent Developments
  13. 6.3 Dorphan S.A.
  14. 6.3.1 Dorphan S.A. Company Information
  15. 6.3.2 Dorphan S.A. Business Overview
  16. 6.3.3 Dorphan S.A. Alpha N-Acetylglucosaminidase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dorphan S.A. Alpha N-Acetylglucosaminidase Product Portfolio
  18. 6.3.5 Dorphan S.A. Recent Developments
  19. 6.4 BioMarin Pharmaceutical Inc.
  20. 6.4.1 BioMarin Pharmaceutical Inc. Company Information
  21. 6.4.2 BioMarin Pharmaceutical Inc. Business Overview
  22. 6.4.3 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Product Portfolio
  24. 6.4.5 BioMarin Pharmaceutical Inc. Recent Developments
  25. 6.5 Alexion Pharmaceuticals, Inc.
  26. 6.5.1 Alexion Pharmaceuticals, Inc. Company Information
  27. 6.5.2 Alexion Pharmaceuticals, Inc. Business Overview
  28. 6.5.3 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Product Portfolio
  30. 6.5.5 Alexion Pharmaceuticals, Inc. Recent Developments
  31. 6.6 Abeona Therapeutics, Inc.
  32. 6.6.1 Abeona Therapeutics, Inc. Company Information
  33. 6.6.2 Abeona Therapeutics, Inc. Business Overview
  34. 6.6.3 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Product Portfolio
  36. 6.6.5 Abeona Therapeutics, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Alpha N-Acetylglucosaminidase Sales by Country
  2. 7.1.1 North America Alpha N-Acetylglucosaminidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alpha N-Acetylglucosaminidase Sales by Country (2021-2026)
  4. 7.1.3 North America Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alpha N-Acetylglucosaminidase Market Size by Country
  6. 7.2.1 North America Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026)
  8. 7.2.3 North America Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alpha N-Acetylglucosaminidase Sales by Country
  2. 8.1.1 Europe Alpha N-Acetylglucosaminidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alpha N-Acetylglucosaminidase Sales by Country (2021-2026)
  4. 8.1.3 Europe Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alpha N-Acetylglucosaminidase Market Size by Country
  6. 8.2.1 Europe Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alpha N-Acetylglucosaminidase Sales by Country
  2. 9.1.1 Asia-Pacific Alpha N-Acetylglucosaminidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alpha N-Acetylglucosaminidase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alpha N-Acetylglucosaminidase Market Size by Country
  6. 9.2.1 Asia-Pacific Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alpha N-Acetylglucosaminidase Sales by Country
  2. 10.1.1 South America Alpha N-Acetylglucosaminidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alpha N-Acetylglucosaminidase Sales by Country (2021-2026)
  4. 10.1.3 South America Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alpha N-Acetylglucosaminidase Market Size by Country
  6. 10.2.1 South America Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026)
  8. 10.2.3 South America Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Country
  2. 11.1.1 Middle East and Africa Alpha N-Acetylglucosaminidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alpha N-Acetylglucosaminidase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alpha N-Acetylglucosaminidase Market Size by Country
  6. 11.2.1 Middle East and Africa Alpha N-Acetylglucosaminidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alpha N-Acetylglucosaminidase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alpha N-Acetylglucosaminidase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alpha N-Acetylglucosaminidase Value Chain Analysis
  2. 12.1.1 Alpha N-Acetylglucosaminidase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alpha N-Acetylglucosaminidase Production Mode & Process
  7. 12.2 Alpha N-Acetylglucosaminidase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alpha N-Acetylglucosaminidase Distributors
  10. 12.2.3 Alpha N-Acetylglucosaminidase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst